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Abstract 
Purpose: To synthesize novel sialylated lactuloses, namely, Neu5Gc-α2,3-lactulose and Neu5Gc-α2,6-
lactulose. 
Methods: ManNGc was chemically synthesized from commercially available N-acetylmannosaime 
(ManNAc), which was used as the donor substrate to synthesize α-(2→3) linkage and α-(2→6) linkage 
sialyllactulose from lactulose via sialyltransferases-catalyzed one-pot multienzyme (OPME) approach. 
The sialylated products were purified by silica gel flash chromatography column. Mass spectrometry 
(MS) and nuclear magnetic resonance (NMR) were used to confirm the purity and characterize the 
structure of the new compounds. 
Results: Sialyllactulose with α-(2→3) linkage (Neu5Gc-α2,3-lactulose) and α-(2→6) linkage (Neu5Gc-
α2,6-lactulose) were efficiently synthesized by an efficient one-pot multienzyme sialylation approach 
from ManNGc, sodium pyruvate, CTP, and lactulose. The molecular weight of the two products, based 
on mass spectral data was 648 Da while NMR data indicated the formation of sialylated glycans.   
Conclusion: Novel sialylated oligosaccharides have been efficiently synthesized from lactulose using 
highly efficient OPME sialylation approaches. Further investigations are required to ascertain the 
probiotic activities for possible applications in pharmaceutical and food industries. 
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Sialic acids are nine-carbon sugars and there are 
over fifty structurally distinct forms of sialic acids 
found in nature. Sialic acids have three basic 
forms, including N-acetylneuraminic acid 
(Neu5Ac), N-glycolylneuraminic acid (Neu5Gc), 
and deaminoneuraminc acid (KDN) [1-3]. 
Sialylated glycoconjugates play important roles in 
physiological and pathological processes, such 
as cellular recognition, bacterial and viral 
infection, and tumor development, differentiation, 
etc [3,4]. Currently, the intestinal microbiome is 
increasingly being recognized as an important 
determinant of health. Sialylated oligosa-
ccharides are known to be one of the receptors 
for pathogens and they could inhibit pathogen 
adhere to the intestinal epithelia [5,6] and block 
the adhesion of Helicobacter pylori to intestinal 
cells [7].  
 
The particular difficulty of the application of 
sialylated oligosaccharides is the lack of 
sufficient material for performing preclinical trials. 
Enzymatic approaches have approved to be one 
of the efficient way to produce many novel 
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synthetic sialylated oligosaccharides which are 
most likely to have antimicrobial actions.  
 
Lactulose (4-O-β-D-galactopyranosyl-D-fructose) 
does not exist in nature. It is usually synthesized 
from lactose by isomerization and bioconversion 
[8-10]. Lactulose is non-absorbable in the upper 
gastrointestinal tract but can be metabolized by 
colonic bacteria [12]. It has been used to treat 
hepatic encephalopathy in patients with 
hyperammonemia [13], and also widely used in 
food industries because of its prebiotic activities 
[14]. On the other hand, non-human sialic acid N-
glycolylneuraminic acid (Neu5Gc) is broadly 
presented in tissues of animals other than human 
and has also been shown to be expressed on 
glycolipids and glycoproteins in human 
melanoma, colon, and breast cancers [15,16]. It 
is interesting to get knowledge of whether 
Neu5Gc-containing lactuloses have any 
increased prebiotic activities. 
 
In this paper, we report here the efficient chemo-
enzymatic synthesis of Neu5Gc-containing 
sialylated lactuloses with α-(2→3) linkage and α-
(2→6) linkage, via one-pot multienzyme 
sialylation approach from chemically synthesized 
ManNGc as the donor substrate and 
commercially available lactulose as the acceptor 
substrate. The outcome of this work should 
provide useful information in the development of 




Materials and reagent 
 
Lactulose was purchased from Carbosynth Ltd 
(Berkshire, UK); CTP was purchased from 
Hangzhou Meiya Pharmaceutical (Hangzhou, 
China); Neu5Ac and N-Acetyl-D-mannosamine 
(ManNAc) were purchased from Ningbo 
Hongxiang Bio-chem (Ningbo, China); Mannose 
was purchased from Shanghai Institute of 
Biotechnology (Shanghai, China); Magnesium 
chloride (MgCl2), p-anisaldehyde, acetoxyacetyl 
chloride, ethyl acetate (EtOAc), methyl alcohol 
(MeOH), n-propanol, ammonia, ethyl alcohol 
(EtOH), acetic acid (HOAc), sodium chloride and 
sodium hydrogen sulfite were of analytical grade 
(AR). Pmaldolase (from Pasteurella multocida), 
NmCSS (a CMPsialic acid synthetase from N. 
meningitidis), PmST1_M144D (α2–3-
sialyltransferase, a Pasteurella multocida 
multifunctional α-2,3-sialyltransferase 1 M144D 
mutant), Pd2-6ST (a recombinant 
Photobacterium damsela α-2,6-sialyltransferase) 
were kindly provided by National 
Glycoengineering research center (NGRC) in 
Shandong University. 
 
Chemical synthesis of ManNGc  
 
(1) ManNH2 .HCl  
 
ManNAc (5 g) was dissolved in 20 mL of 2.5 M 
HCl. The mixture was reacted at 60 °C (water-
bath) for 1 to 2 h. After removal of the solvent, 




To a stirred mixture of ManNH2-HCl (2.16 g) in 
dry MeOH (50 mL), solid K2CO3 (6.91 g) was 
added. The mixture was stirred for 30 min and 
acetoxyacetyl chloride (2.15 mL) was added. 
When the starting material was almost 
consumed, the reaction mixture was 
concentrated and purified by silica flash 
chromatography (EtOAc:MeOH: H2O = 5 : 2 : 1) 




ManNGcAc (1 g) was dissolved in dry MeOH (20 
mL), and NaOMe (200 mg) was then added to 
give pH about 9. The reaction mixture was stirred 
for overnight at rt. Resin (H+) was added to the 
reaction mixture to neutralize the NaOMe. After 
filtration and concentration, the desired ManNGc 




Scheme 1: Chemical synthesis of ManNGc from ManNAc 
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Scheme 2: Enzymatic sialylation of lactulose via OPME sialylation system 
 
Enzymatically synthesis of Neu5Gcα2-
3Lactulose and Neu5Gcα2-6Lactulose  
 
(1) Small-scale reaction assays  
 
The enzymatic assays were carried out in a total 
volume of 10 μL in Tris–HCl buffer (100 mM, pH 
8.5) containing Lactulose (10 mM), ManNGc (15 
mM), sodium pyruvate (60 mM), CTP (15 mM), 
MgCl2 (20 mM), Pmaldolse (2 μg), and 
PmST1_M144D (5 μg) or Pd26ST (5 μg). 
Reactions were allowed to proceed for 4.5 h at 
37 °C. The reaction process was monitored by 
thin layer chromatography (TLC) and mass 
spectra.  
 
(2) Preparation-scale reactions 
 
ManNGc (100 mg), sodium pyruvate (278 mg), 
lactulose (119 mg), and CTP (285 mg) were 
dissolved in Tris-HCl buffer (10 mL, 100 mM, pH 
8.5) containing MgCl2 (20 mM) and Pmaldolase 
(3 mg), NmCSS (3 mg), PmST1_M144D (5 mg, 
for synthesis of Neu5Gcα2-3Lactulose) or 
Pd26ST (5 mg, for synthesis of Neu5Gcα2-
6Lactulose). The reactions were incubated in an 
incubator shaker at 37 °C for overnight with 
agitation at 110 rpm. The reactions were 
monitored by TLC (n-propanol:H2O:NH4·OH = 5: 
2:1, by volume). When an optimal yields were 
achieved, the reactions were stopped by adding 
the same volume of cold EtOH and kept at 4 °C 
for 30 min, then centrifuged (7000 rpm, 30 min). 
The supernatant was concentrated and the 
residue was purified by silica gel column (eluting 
solvent: EtOAc : MeOH : H2O = 6 : 2 : 1 and 




Purified samples (0.5 mg) were dissolved in 100 
μL distilled water at room temperature. Mass 
Spectrum analyses were carried out on a TQD 
LC/MS system (Waters, USA), equipped with 
quaternary pump, vacuum degasser, column 
compartment, auto-injector, diode-array detector 
(DAD), and ion-trap mass spectrometer with 
electrospray ionization (ESI) interface. Scan 




Purified sample (15 mg) were dissolved in 0.5 
mL D2O at room temperature. NMR spectra were 
recorded on a Bruker Avance III HD 600 
spectrometer (Bruker BioSpin, Billerica, MA, 






As shown in Figure 1, ManNAc, ManNH2, 
ManNGc, and ManNGcAc were separated by the 
developing solvent (EtOAc:MeOH:H2O = 6:2:1) 
in thin layer chromatography (TLC). Silica gel 
flash chromatography column was used to purify 
the products in series of gradient eluting solvent. 
 
 
Figure 1:  TLC of synthesis of ManNGc. Key: 1 - 
ManNAc; 2 - ManNH2; 3 - ManNGcAc; 4 - 
ManNGc  
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Figure 2: TLC of small reactions of Neu5Gcα2-
3Lactulose and Neu5Gcα2-6Lactulose. L, 
Lactulose; 1, reaction of Neu5Gcα2-3lactulose; 
2, reaction of Neu5Gcα2-6lactulose)  
 
As shown in Figure 2, using lactulose as the 
sialyltransferase acceptor, α2-3-sialylated and 
α2-6-sialylated trisaccharides were readily 





Figure 3: TLC of purified Neu5Gcα2-3Lactulose 
and Neu5Gcα2-6Lactulose. L, Lactulose; 1, 




Figure 4: Mass spectrum of purified Neu5Gcα2-3Lactulose and Neu5Gcα2-6Lactulose. Note: a = 
Neu5Gcα2-3Lactulose; b = Neu5Gcα2-6Lactulose. 
 
The purified products were checked by TLC and 
Mass spectrum. Figure 3 showed the compounds 
were pure. From Figure 4, the molecular weight 
of Neu5Gcα2-3lactulose and Neu5Gcα2-
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6Lactulose based on MS data both showed 
about 648 Da (the mass of lactulose is 342 Da), 
these results confirmed that the obtained 




As shown in Figure 5, the structures of 
sialyllactuloses were confirmed by 1H and 13C 
NMR spectra. The NMR data are as follows:  
 
Neu5Gcα2-3Lactulose: Yield, 85 %; white solid. 
13C NMR (151 MHz, D2O, Figure 5a) δ 175.73, 
173.83, 100.32, 99.77, 98.02, 77.24, 75.61, 
75.12, 72.53, 71.81, 69.19, 68.05, 67.96, 67.48, 
66.55, 66.03, 63.87, 62.91, 62.48, 61.09, 60.94, 
60.47, 51.35, 39.71. 1H NMR (600 MHz, D2O, 
Figure 5b) δ 4.55 (d, J = 7.8 Hz, 0.7 H), 4.45 (d, 
J = 7.8 Hz, 0.3 H), 4.20– 3.43 (m, 23 H), 2.67 
(dd, J = 12.0 and 4.8 Hz, 1 H), 1.71 (t, J = 12.0 
Hz, 1 H).  
 
Neu5Gcα2-6Lactulose: Yield, 80 %; white solid. 
13C NMR (151 MHz, D2O, Figure 6a) δ 175.69, 
173.47, 100.30, 98.09, 96.60, 78.18, 74.32, 
73.61, 72.42, 72.23, 71.75, 70.64, 68.61, 68.24, 
68.00, 67.05, 66.26, 63.85, 62.97, 62.54, 60.94, 
51.45, 40.12. 1H NMR (600 MHz, D2O, Figure 
6b) δ 4.44 (d, J = 7.8 Hz, 0.6 H), 4.35 (d, J = 7.8 
Hz, 0.4 H), 4.24– 3.46 (m, 23 H), 2.62 (dd, J = 





Figure 5: 1H and 13C NMR spectra of sialyllactuloses. Note: a = 13C NMR of Neu5Gcα2-3Lactulose; b 
= 1H NMR of Neu5Gcα2-3lactulose 
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Figure 6: 1H and 13C NMR spectra of sialyllactuloses. Note: a = 13C NMR of Neu5Gcα2-6Lactulose; b 




The sialic acid modification on cell surface 
glycoproteins and glycolipids plays a crucial role 
in many biological processes, including cell 
adhesion, antigen recognition and signal 
transduction [17]. Studies have shown that 
sialylated glycans have a good prospect in food, 
especially the developing nervous system in 
infants [18]. Chemical synthesis of sialylated 
glycans is very difficult, and the enzymatic 
synthesis provides an effective method for 
generating sialyl linkages [19]. 
 
In this paper, in order to obtain Neu5Gc-
containing sialosides via enzymatic approaches, 
firstly ManNGc was synthezied from ManNAc. 
We found that most ManNGcAc (around 70 %) 
was deacetylated to ManNGc because of 
alkaline condition when the reaction of formation 
of ManNGcAc prolonged to 48 h. The two 
products were separated by silica gel flash  
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Scheme 3: Synthesis of ManNGc  
 
Chromatography. Therefore, Scheme 1 can be 
presented as following Scheme 3: 
 
Then ManNGc was used as the donor substrate 
in the OPME sialylation system to produce the 
corresponding sialosides. Therein, sialic acid 
aldolase (Pmaldolase, for synthesis of Neu5Gc), 
CMP-sialic acid synthetase (NmCSS, for 
synthesis of CMP-Neu5Gc), and sialyltransferase 
(PmST1_M144D, for synthesis of α2-3-linked 
sialoside; Pd26ST, for α2-6-linked sialoside) 
without the isolation of intermediates. In small-
scale reactions assays, around 55% lactulose in 
the reaction system could not reacted 
completely, probably due to non-sufficient 
enzymes or decomposition of CTP. The yield can 
be solved by adding enough enzyme or CTP 
during the progress of the enzymatic reactions. 
Indeed, during large-scale reactions additional 
amounts of enzyme and CTP were added when 
TLC analysis showed the reactions not going 
further. The sialylation yield was up to around 85 





Two novel Neu5Gc-containing sialyllactulose 
with α-(2→3) linkage and α-(2→6) linkage have 
been efficiently synthesized by OPME sialylation 
from ManNGc, sodium pyruvate, CTP and 
lactulose. As it’s important to find new sialylated 
oligosaccharides with stronger antibacterial 
and/or probiotic activities, the two obtained 
sialylated lactuloses would be very useful 
substrates for determining their abilities of 
inhibiting pathogenic bacterial binding to 
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